ARTICLE | Company News
Alteon, HaptoGuard deal
April 24, 2006 7:00 AM UTC
ALT said it will acquire inflammation and cardiovascular company HaptoGuard in a stock deal. ALT will issue $5.3 million of stock (about 22.5 million shares) to HaptoGuard shareholders. Also, HaptoGuard shareholders will receive an additional $3.5 million of ALT stock that is currently held by Genentech Inc. (DNA, South San Francisco, Calif.). All told, HaptoGuard shareholders will own 31% of the combined company. ...